All In Biotech

Drug Trial Radar · NCT03362177

Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer

RECITE: A Phase 3 Randomized Placebo-controlled Double-blind Study of Romiplostim for the Treatment of Chemotherapy- Induced Thrombocytopenia in Patients Receiving Oxaliplatin-based Chemotherapy for Treatment of Gastrointestinal, Pancreatic, or Colorectal Cancer

Last checked: Nov 20, 2026Latest source record: Oct 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 165 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

165

Actual

Start

Sep 30, 2019

Primary completion

Jan 25, 2024

Study completion Jan 9, 2025

Sponsor

Lead sponsor
AmgenAmgen (AMGN)
Sponsor type
Industry
First posted
Dec 5, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 100 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects with Gastrointestinal, Pancreatic, or Colorectal Cancer

Conditions

  • Chemotherapy-induced Thrombocytopenia

Interventions

  • RomiplostimBiological

    This study is designed to study Romiplostim for the treatment of chemotherapy-induced thrombocytopenia (CIT) in patients receiving chemotherapy for the treatment of gastrointestinal/colorectal/pancreatic cancer.

  • PlaceboOther

    Placebo Comparator

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants Who Had Thrombocytopenia-induced Dose ModificationTime frame: Day 1 up to Week 12

Locations

117 sites in 20 countries. Site status is shown where the registry gives one.

  • Saint Bernards Medical Center

    Jonesboro, Arkansas

  • Pacific Cancer Medical Center Inc

    Anaheim, California

  • University of California Irvine

    Orange, California

  • Colorado West Healthcare System dba Grand Valley Oncology

    Grand Junction, Colorado

  • Mid Florida Hematology and Oncology Centers PA

    Orange City, Florida

  • Oncology and Hematology Associates of West Broward, PA

    Tamarac, Florida

  • Cleveland Clinic Florida

    Weston, Florida

  • Orchard Healthcare Research Inc

    Skokie, Illinois

  • Christus Saint Frances Cabrini Hospital

    Alexandria, Louisiana

  • University Medical Center New Orleans

    New Orleans, Louisiana

  • Christus Highland Cancer Treatment Center

    Shreveport, Louisiana

  • Mercy Medical Center

    Baltimore, Maryland

  • American Oncology Partners, PA

    Bethesda, Maryland

  • Massachusetts General Hospital Cancer Center

    Boston, Massachusetts

  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts

  • Hattiesburg Clinic Hematology/Oncology

    Hattiesburg, Mississippi

  • Oncology Hematology Associates

    Springfield, Missouri

  • Morristown Medical Center

    Morristown, New Jersey

  • Regional Cancer Care Associates

    Sparta, New Jersey

  • The Center for Cancer and Blood Disorders

    Fort Worth, Texas

  • Medical Oncology Associates PS

    Spokane, Washington

  • Yakima Valley Memorial Hospital

    Yakima, Washington

  • Centro de Diagnostico Investigacion y Tratamiento

    Salta, Argentina

  • Hospital Universitario Fundacion Favaloro

    Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina

  • Instituto Oncologico Cordoba

    Córdoba, Córdoba Province, Argentina

  • Centro de Investigaciones Clínicas Clínica Viedma

    Viedma, Río Negro Province, Argentina

  • Landeskrankenhaus Steyr

    Steyr, Austria

  • Universitaetsklinikum Allgemeines Krankenhaus Wien

    Vienna, Austria

  • Instituto de Oncologia do Parana

    Curitiba, Paraná, Brazil

  • Vencer e Oncoclinica

    Teresina, Piauí, Brazil

  • Centro de Pesquisa da Serra Gaucha - Cepesg

    Caxias do Sul, Rio Grande do Sul, Brazil

  • Catarina Pesquisa Clinica

    Itajaí, Santa Catarina, Brazil

  • Loema Instituto de Pesquisa Clinica e Consultores Ltda

    Campinas, São Paulo, Brazil

  • Casa de Saude Santa Marcelina

    São Paulo, São Paulo, Brazil

  • Complex Oncology Center - Ruse EOOD

    Rousse, Bulgaria

  • Medical Center Nadezhda Clinical EOOD

    Sofia, Bulgaria

  • Specialized Hospital for Active Treatment of Oncology EAD

    Sofia, Bulgaria

  • Cape Breton Cancer Centre, Nova Scotia Health Authority

    Sydney, Nova Scotia, Canada

  • Grand River Regional Cancer Centre at Grand River Hospital

    Kitchener, Ontario, Canada

  • Fundacion Colombiana de Cancerologia Clinica Vida

    Medellín, Antioquia, Colombia

Showing 40 of 117 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.